Fundraising FoxHI-Bio
acquired by Biogen9 known investors
Find your way into HI-Bio
Sign up to find every way you can get introduced to HI-Bio
- Your email: who you already know at HI-Bio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the HI-Bio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Biotech company developing antibodies to treat autoimmune and inflammatory diseases.
Investors · 9
How we know: Alpha Wave Global's portfolio page · prnewswire.com · Not right? Tell us
How we know: Arkin Capital's portfolio page · Not right? Tell us
How we know: Arkin Digital Health's portfolio page · Not right? Tell us
How we know: Jeito Capital's portfolio page · prnewswire.com · Not right? Tell us
How we know: press coverage · funding news · Not right? Tell us
How we know: Viking Global's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · prnewswire.com · funding news · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$95M disclosed across 1 round · 2024
- $95MSeries BJan 2024 · 2 sources
Alpha Wave Global (lead), ARCH Venture Partners, Arkin Bio Capital, Jeito Capital, Viking Global Investors
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does HI-Bio do?
- Biotech company developing antibodies to treat autoimmune and inflammatory diseases.
- Who are HI-Bio's investors?
- HI-Bio's investors include Alpha Wave Global, Arkin Capital, Arkin Digital Health, Jeito Capital, Monograph Capital Partners, Viking Global, ARCH Venture Partners, Viking Global Investors.
- How much funding has HI-Bio raised?
- HI-Bio has disclosed $95M raised across 1 round.
- Who acquired HI-Bio?
- HI-Bio was acquired by Biogen.